SCHEMBL6504832

SCHEMBL6504832

NC(=O)Nc1cn(-c2ccc(-c3ccc(F)c(Cl)c3)cc2)nc1C(N)=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN2B Q13224 6/20 0.41
GRIN1 Q05586 2/20 0.41
CASP1 P29466 1/20 0.40
ITK Q08881 1/20 0.40
ICMT O60725 2/20 0.39
ALDH1A1 P00352 4/20 0.39
KDM4E B2RXH2 3/20 0.39
MAPT P10636 2/20 0.39
KIF11 P52732 2/20 0.39
LMNA P02545 1/20 0.39
HPGD P15428 1/20 0.39
KMT2A Q03164 3/20 0.39
NPC1 O15118 1/20 0.39
GAA P10253 1/20 0.39
PKM P14618 1/20 0.39
RAB9A P51151 1/20 0.39
MEN1 O00255 2/20 0.38
HTT P42858 1/20 0.38
MC4R P32245 1/20 0.38
MAP4K4 O95819 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6497902 0.90 SCN9A (0.43) GRIN2BGRIN1CASP1ITKICMT
SCHEMBL6507842 0.90 IDO1 (0.45) GRIN2BITKALDH1A1KDM4EMAPT
SCHEMBL6506219 0.87 ITK (0.42) GRIN2BGRIN1ITKALDH1A1KDM4E
SCHEMBL6467616 0.85 KIF11 (0.43) ITKALDH1A1KDM4EMAPTKIF11
SCHEMBL6501596 0.85 IKBKB (0.47) ITKALDH1A1KDM4EMAPTLMNA
SCHEMBL6504415 0.85 KDM4E (0.50) ITKALDH1A1KDM4EMAPTLMNA
SCHEMBL6505030 0.84 ITK (0.42) ITKALDH1A1KDM4EMAPTKIF11
SCHEMBL6504083 0.83 AXL (0.41) ITKALDH1A1KDM4EMAPTKIF11
SCHEMBL6465833 0.83 ALDH1A1 (0.53) ITKALDH1A1KDM4EMAPTLMNA
SCHEMBL6499042 0.82 KDM4E (0.49) ITKALDH1A1KDM4EMAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050197338-A1 Substituted pyrazole urea compounds for the treatment of inflammation PHARMACIA AND UPJOHN COMPANY LLC 2005-09-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050197338-A1 Substituted pyrazole urea compounds for the treatment of inflammation IL4, ARG2, CASP4 GRIN2B 1526/4885GRIN1 2105/4885CASP1 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.